Equasens Société anonyme (EPA:EQS)

Market Cap	529.10M -29.7%
Revenue (ttm)	224.73M +3.3%
Net Income	36.31M -18.7%
EPS	2.40 -18.4%
Shares Out	15.03M
PE Ratio	14.67
Forward PE	11.26
Dividend	1.25 (3.55%)
Ex-Dividend Date	Jul 1, 2026

Volume	5,782
Open	35.70
Previous Close	35.65
Day's Range	35.20 - 35.80
52-Week Range	33.70 - 53.70
Beta	0.56
Analysts	Strong Buy
Price Target	55.68 (+58.18%)
Earnings Date	Sep 28, 2026

About Equasens Société anonyme

Equasens Société anonyme provides healthcare IT solutions in Europe. The company publishes software and connected solutions for pharmacies, medical-social establishments, doctors, and medical auxiliaries. It also manufactures connected electronic devices and appliances for healthcare professionals and patients. In addition, the company is financing solutions for rental properties for healthcare professionals and other tertiary sectors. It serves healthcare facilities and private healthcare professionals. The company was incorporated in 1996 and...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1996
• Employees: 1,400
• Stock Exchange: Euronext Paris
• Ticker Symbol: EQS

Financial Performance

In 2024, Equasens Société anonyme's revenue was 216.75 million, a decrease of -1.38% compared to the previous year's 219.79 million. Earnings were 36.23 million, a decrease of -22.99%.

Analyst Summary

According to 4 analysts, the average rating for EQS stock is "Strong Buy." The 12-month stock price target is €55.68, which is an increase of 58.18% from the latest price.

Price Target

€55.68

(58.18% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error